Complete Genomics, Inc. (GNOM) Posts Q2 EPS Loss of $0.56, Revenue Falls Below Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St futures up as oil slips; telecoms pressured by SpaceX spectrum deal
- Oil falls as Trump comments on Iran talks ease supply concerns
- UBS flags level in gold prices where dip buyers will likely emerge
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- Investors need sustained Fed cuts to move cash off sidelines: BofA's Hartnett
| COMPLETE GENOM (NASDAQ: GNOM) | Delayed: 65.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.83 | 52 Week High | $3.50 | |||
| Open | $65.83 | 52 Week Low | $1.57 | |||
| Day High | $65.83 | P/E | N/A | |||
| Day Low | $65.83 | EPS | $-2.35 | |||
| Volume | 40 | |||||
